**Acknowledgment**

We would like to thank the library staff from Texas Tech University Health Sciences Center, Lubbock for their extraordinary support and assistance. On a special note, we would like to thank again Carrie Gassett who showed great interest and support in our project.

## **Author details**

Thomas Nelius, Christopher Winter, Julia Willingham and Stephanie Filleur

Texas Tech University Health Sciences Center, Departments of Urology and Microbiology, Lubbock, USA

## **References**


tract epithelial cells by modulating virulence gene expression. J Urol, Apr Electronic), 185(4), 1526-1531.

[16] Czaja, C. A., et al. (2007). Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infect Dis Obstet Gyne‐

Immune-Based Treatment Strategies for Patients with Recurrent Urinary Tract Infections – Where Are We?

http://dx.doi.org/10.5772/52913

171

[17] Dani, C., et al. (2002). Probiotics feeding in prevention of urinary tract infection, bac‐ terial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-

[18] Darouiche, R. O., et al. (1999). Efficacy of antimicrobial-impregnated bladder cathe‐ ters in reducing catheter-associated bacteriuria: a prospective, randomized, multicen‐

[19] Darouiche, R. O., et al. (2005). Bacterial interference for prevention of urinary tract in‐ fection: a prospective, randomized, placebo-controlled, double-blind pilot trial. Clin

[20] De Caprio, A. P. (1999). The toxicology of hydroquinone--relevance to occupational and environmental exposure. Crit Rev Toxicol, May 1999), Print), 29(3), 283-330. [21] Domadia, P. N., et al. (2008). Berberine targets assembly of Escherichia coli cell divi‐

[22] Frohne, D. (1970). The urinary disinfectant effect of extract from leaves uva ursi].

[23] Gill, A O &Holley, R A.(2006). Disruption of Escherichia coli, Listeria monocytogenes and Lactobacillus sakei cellular membranes by plant oil aromatics. Int J Food Micro‐

[24] Gonzalez-Chamorro, F., & et, al. [. Urinary tract infections and their prevention]. Ac‐

[25] Guay, D. R. (2009). Cranberry and urinary tract infections. Drugs, Print), 69(7),

[26] Guay, D. R. (2001). An update on the role of nitrofurans in the management of urina‐

[27] Ha, U S &Cho, Y H.(2008). Immunostimulation with Escherichia coli extract: preven‐ tion of recurrent urinary tract infections. Int J Antimicrob Agents, Suppl 1, No. (Feb

[28] Head, K. A. (2008). Natural approaches to prevention and treatment of infections of

[29] Hopkins, W. J., et al. (2007). Vaginal mucosal vaccine for recurrent urinary tract in‐ fections in women: results of a phase 2 clinical trial. J Urol, Apr 2007), quiz 1591,

the lower urinary tract. Altern Med Rev, Sep 2008), Print), 13(3), 227-244.

sion protein FtsZ. BiochemistryMar 11 2008), Print), 47(10), 3225-3234.

blind study. Biol Neonate, Aug 2002), , 82(2), 103-108.

Infect Dis, Nov 15 2005), Electronic), 41(10), 1531-1534.

Planta Med, Jan 1970), Print), 18(1), 1-25.

biol, Apr 15 2006), Print), 108(1), 1-9.

775-807.

2008), Print), 31, S63-S67.

0022-5347 (Print), 177(4), 1349-1353.

tas Urol Esp, Jan Electronic), 36(1), 48-53.

ry tract infections. Drugs, Print), 61(3), 353-364.

ter clinical trial. UrologyDec 1999), Electronic), 54(6), 976-981.

col, , 2007(2007), 35387.


[16] Czaja, C. A., et al. (2007). Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infect Dis Obstet Gyne‐ col, , 2007(2007), 35387.

tract epithelial cells by modulating virulence gene expression. J Urol, Apr Electronic),

[3] Anukam, K. C., et al. (2009). Probiotic Lactobacillus rhamnosus GR-1 and Lactobacil‐ lus reuteri RC-14 may help downregulate TNF-Alpha, IL-6, IL-8, IL-10 and IL-12 (p70) in the neurogenic bladder of spinal cord injured patient with urinary tract in‐

[4] Avorn, J., et al. (1994). Reduction of bacteriuria and pyuria after ingestion of cranber‐

[5] Beaux, D., Fleurentin, J. ., & Mortier, F. (1999). Effect of extracts of Orthosiphon stam‐ ineus Benth, Hieracium pilosella L., Sambucus nigra L. and Arctostaphylos uva-ursi

[6] Beerepoot, M. A., et al. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern

[7] Beretz, A., Anton, R. ., & Stoclet, J. C. (1978). Flavonoid compounds are potent inhibi‐ tors of cyclic AMP phosphodiesterase. ExperientiaAug 15 1978), Print), 34(8),

[8] Bessler, W. G., et al. (2009). Immunomodulating effects of OM-89, a bacterial extract from Escherichia coli, in murine and human leukocytes. Arzneimittelforschung,

[9] Billips, B. K., et al. (2009). A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. J Infect Dis, Jul 15 2009), Print), 200(2),

[10] Bishop, B. L., et al. (2007). Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med, May 2007), Print), 13(5), 625-630.

[11] Bodel, P. T., Cotran, R. ., & Kass, E. H. (1959). Cranberry juice and the antibacterial action of hippuric acid. J Lab Clin Med, No. (Dec 1959), Print), 54, 881-888.

[12] Bruce, A. W. ., & Reid, G. (1988). Intravaginal instillation of lactobacilli for preven‐ tion of recurrent urinary tract infections. Can J Microbiol, Mar 1988), , 34(3), 339-343.

[13] Bruce, A. W. ., & Reid, G. (2003). Probiotics and the urologist. Can J Urol, Apr 2003), ,

[14] Burt, S. (2004). Essential oils: their antibacterial properties and potential applications in foods--a review. Int J Food Microbiol, Aug 1 2004), Print), 94(3), 223-253.

[15] Cernakova, M. ., & Kostalova, D. (2002). Antimicrobial activity of berberine--a con‐ stituent of Mahonia aquifolium. Folia Microbiol (Praha), Print), 47(4), 375-378.

(L.) Spreng. in rats. Phytother Res, May 1999), X (Print), 13(3), 222-225.

fections: a two-case study. Adv Urol, Vol. Print)(2009), 680363.

ry juice. Jama, Mar 9 1994), Print), 271(10), 751-754.

Med, Jul 25 Electronic), 171(14), 1270-1278.

185(4), 1526-1531.

170 Recent Advances in the Field of Urinary Tract Infections

1054-1055.

263-272.

10(2), 1785-1789.

Print), 59(11), 571-577.


[30] Howell, A. B., et al. (2005). A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry, Sep 2005), Print), 66(18), 2281-2291.

[43] Ofek, I., Goldhar, J. ., & Sharon, N. (1996). Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. Adv Exp Med Biol, Print), 408(1996), 179-183.

Immune-Based Treatment Strategies for Patients with Recurrent Urinary Tract Infections – Where Are We?

http://dx.doi.org/10.5772/52913

173

[44] Ofek, I., et al. (1991). Anti-Escherichia coli adhesin activity of cranberry and blueber‐

[45] Ohnishi, R., et al. (2006). Urinary excretion of anthocyanins in humans after cranber‐ ry juice ingestion. Biosci Biotechnol Biochem, Jul 2006), Print), 70(7), 1681-1687.

[46] Ohno, T., et al. (2003). Antimicrobial activity of essential oils against Helicobacter py‐

[47] Osset, J., et al. (2001). Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect

[48] Pereira, R. S., et al. (2004). Antibacterial activity of essential oils on microorganisms isolated from urinary tract infection]. Rev Saude Publica, Apr 2004), , 38(2), 326-328.

[49] Perez-Lopez, F. R., Haya, J. ., & Chedraui, P. (2009). Vaccinium macrocarpon: an in‐ teresting option for women with recurrent urinary tract infections and other health

[50] Raz, R., Chazan, B. ., & Dan, M. (2004). Cranberry juice and urinary tract infection.

[51] Raz, R. ., & Stamm, W. E. (1993). A controlled trial of intravaginal estriol in postme‐ nopausal women with recurrent urinary tract infections. N Engl J Med, Sep 9 1993),

[52] Reid, G., Bruce, A. W. ., & Taylor, M. (1992). Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infec‐

[53] Reid, G., et al. (1985). Prevention of urinary tract infection in rats with an indigenous

[54] Russo, T. A., et al. (2003). The Siderophore receptor IroN of extraintestinal pathogen‐ ic Escherichia coli is a potential vaccine candidate. Infect Immun, Dec 2003), Print),

[55] Scazzocchio, F., et al. (2001). Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. Planta Med, Aug 2001), Print), 67(6), 561-564.

[56] Schaeffer, A. J., Story, K. O. ., & Johnson, S. M. (1988). Effect of silver oxide/trichloroi‐ socyanuric acid antimicrobial urinary drainage system on catheter-associated bacter‐

[57] Schierholz, J. M. ., & Beuth, J. (2001). Implant infections: a haven for opportunistic

Lactobacillus casei strain. Infect Immun, Aug 1985), , 49(2), 320-324.

benefits. J Obstet Gynaecol Res, Aug 2009), Print), 35(4), 630-639.

Clin Infect Dis, May 15 2004), Electronic), 38(10), 1413-1419.

tions. Clin Ther, Jan-Feb 1992), , 14(1), 11-16.

iuria. J Urol, Jan 1988), Print), 139(1), 69-73.

bacteria. J Hosp Infect, Oct 2001), Print), 49(2), 87-93.

ry juices. N Engl J Med, May 30 1991), Print), 324(22), 1599.

lori. Helicobacter, Jun 2003), Print), 8(3), 207-215.

Dis, Feb 1 2001), , 183(3), 485-491.

Print), 329(11), 753-756.

71(12), 7164-7169.


[43] Ofek, I., Goldhar, J. ., & Sharon, N. (1996). Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. Adv Exp Med Biol, Print), 408(1996), 179-183.

[30] Howell, A. B., et al. (2005). A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry, Sep 2005), Print), 66(18), 2281-2291.

[31] Ishida, H., et al. (1998). In vitro and in vivo activities of levofloxacin against biofilmproducing Pseudomonas aeruginosa. Antimicrob Agents Chemother, Jul 1998),

[32] Jacobsen, S. M., et al. (2008). Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev, Jan 2008), Electron‐

[33] Jepson, R G &Craig, J C.(2008). Cranberries for preventing urinary tract infections.

[34] Jepson, R. G., Mihaljevic, L. ., & Craig, J. (2000). Cranberries for treating urinary tract infections. Cochrane Database Syst Rev, Vol. X (Electronic)(2), CD001322.

[35] Johnson, J. R., Delavari, P. ., & Azar, M. (1999). Activities of a nitrofurazone-contain‐ ing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacte‐ ria characteristic of catheter-associated urinary tract infection. Antimicrob Agents

[36] Klein, T et al. FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation. J Med Chem, Vol. 53,

[37] Kontiokari, T., et al. (2001). Randomised trial of cranberry-lingonberry juice and Lac‐ tobacillus GG drink for the prevention of urinary tract infections in women. Bmj, Jun

[38] Kubo, M., et al. (1990). Pharmacological studies on leaf of Arctostaphylos uva-ursi (L.) Spreng. I. Combined effect of 50% methanolic extract from Arctostaphylos uvaursi (L.) Spreng. (bearberry leaf) and prednisolone on immuno-inflammation]. Yaku‐

[39] Lavigne, J. P., et al. (2008). In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vacci‐ nium macrocarpon (cranberry) capsules. Clin Microbiol Infect, Apr 2008), X (Print),

[40] Liu, Y., et al. (2006). Role of cranberry juice on molecular-scale surface characteristics and adhesion behavior of Escherichia coli. Biotechnol Bioeng, Feb 5 2006), Print),

[41] Mac, Micking. J., Xie, Q. W. ., & Nathan, C. (1997). Nitric oxide and macrophage

[42] Newman, D. K. (1998). Managing indwelling urethral catheters. Ostomy Wound

Cochrane Database Syst Rev, Vol. X (Electronic)(1), CD001321.

Chemother, Dec 1999), Print), 43(12), 2990-2995.

30 2001), Print), 322(7302), 1571.

14(4), 350-355.

93(2), 297-305.

gaku Zasshi, Jan 1990), Print), 110(1), 59-67.

function. Annu Rev Immunol, Print), 15(1997), 323-350.

Manage, Dec 1998), passim, 0889-5899 (Print), 44(12), 26-28.

No. 24, (Dec 23 pp. 8627-8641, 1520-4804 (Electronic)

Print), 42(7), 1641-1645.

172 Recent Advances in the Field of Urinary Tract Infections

ic), 21(1), 26-59.


[58] Schindler, G., et al. (2002). Urinary excretion and metabolism of arbutin after oral ad‐ ministration of Arctostaphylos uvae ursi extract as film-coated tablets and aqueous solution in healthy humans. J Clin Pharmacol, Aug 2002), Print), 42(8), 920-927.

[71] Wellens, A., et al. (2008). Intervening with urinary tract infections using anti-adhe‐ sives based on the crystal structure of the FimH-oligomannose-3 complex. PLoS One,

Immune-Based Treatment Strategies for Patients with Recurrent Urinary Tract Infections – Where Are We?

http://dx.doi.org/10.5772/52913

175

[72] Wilson, M., Seymour, R. ., & Henderson, B. (1998). Bacterial perturbation of cytokine

[73] Wollenweber, E. (1988). Occurrence of flavonoid aglycones in medicinal plants. Prog

[74] Xia, Y., Yamagata, K. ., & Krukoff, T. L. (2006). Differential expression of the CD14/ TLR4 complex and inflammatory signaling molecules following i.c.v. administration

[75] Yarnell, E. (2002). Botanical medicines for the urinary tract. World J Urol, Nov 2002),

networks. Infect Immun, Jun 1998), , 66(6), 2401-2409.

Clin Biol Res, Print), 280(1988), 45-55.

of LPS. Brain Res, Jun 20 2006), , 1095(1), 85-95.

Electronic), 3(4), e2040.

Print), 20(5), 285-293.


[71] Wellens, A., et al. (2008). Intervening with urinary tract infections using anti-adhe‐ sives based on the crystal structure of the FimH-oligomannose-3 complex. PLoS One, Electronic), 3(4), e2040.

[58] Schindler, G., et al. (2002). Urinary excretion and metabolism of arbutin after oral ad‐ ministration of Arctostaphylos uvae ursi extract as film-coated tablets and aqueous solution in healthy humans. J Clin Pharmacol, Aug 2002), Print), 42(8), 920-927. [59] Schmidt, B. M., et al. (2004). Effective separation of potent antiproliferation and anti‐ adhesion components from wild blueberry (Vaccinium angustifolium Ait.) fruits. J

[60] Seeram, N. P. (2008). Berry fruits for cancer prevention: current status and future

[61] Sikkema, J;de., Bont, J. A. ., & Poolman, B. (1994). Interactions of cyclic hydrocarbons with biological membranes. J Biol Chem, Mar 18 1994), Print), 269(11), 8022-8028. [62] Simpson, D. (1998). Buchu--South Africa's amazing herbal remedy. Scott Med J, Dec

[63] Smith-Palmer, A., Stewartt, J. ., & Fyfe, L. (2002). Inhibition of listeriolysin O and phosphatidylcholine-specific production in Listeria monocytogenes by subinhibitory concentrations of plant essential oils. J Med Microbiol, Jul 2002), , 51(7), 567-574. [64] Spiegel, C. A., et al. (1980). Anaerobic bacteria in nonspecific vaginitis. N Engl J Med,

[65] Stothers, L. (2002). A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in

[66] Sun, D., Abraham, S. N. ., & Beachey, E. H. (1988). Influence of berberine sulfate on synthesis and expression of Pap fimbrial adhesin in uropathogenic Escherichia coli.

[67] Sun, D., Courtney, H. S. ., & Beachey, E. H. (1988). Berberine sulfate blocks adherence of Streptococcus pyogenes to epithelial cells, fibronectin, and hexadecane. Antimi‐

[68] Thankavel, K., et al. (1997). Localization of a domain in the FimH adhesin of Escheri‐ chia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. J Clin In‐

[69] Trautner, B W &Darouiche, R O.(2004). Catheter-associated infections: pathogenesis affects prevention. Arch Intern Med, Apr 26 2004), Print), 164(8), 842-850.

[70] Turi, M., et al. (1997). Influence of aqueous extracts of medicinal plants on surface hy‐ drophobicity of Escherichia coli strains of different origin. Apmis, Dec 1997), Print),

Antimicrob Agents Chemother, Aug 1988), Print), 32(8), 1274-1277.

crob Agents Chemother, Sep 1988), Print), 32(9), 1370-1374.

vest, Sep 1 1997), Print), 100(5), 1123-1136.

105(12), 956-962.

Agric Food Chem, Oct 20 2004), Print), 52(21), 6433-6442.

women. Can J Urol, Jun 2002), Print), 9(3), 1558-1562.

1998), , 43(6), 189-191.

174 Recent Advances in the Field of Urinary Tract Infections

Sep 11 1980), , 303(11), 601-607.

prospects. J Agric Food Chem, Feb 13 2008), Print), 56(3), 630-635.

